Content related to Improving Care for Babies With Bronchopulmonary Dysplasia

The Infant Chronic Lung Disease Program provides comprehensive and coordinated care for babies and children with severe bronchopulmonary dysplasia.

One year after leaving Children’s Hospital Los Angeles, 2-year-old Quinn is beating the odds and thriving despite a severe birth defect.

Under a $1.5 million federal grant, Children’s Hospital Los Angeles is investing in innovative interdisciplinary leadership education in the field.

A new clinical trial aims to shed light on how to best treat a patent ductus arteriosus in the most fragile infants.

Virtual visits allow providers to assess home setup and safety—and help families breathe easier.

Children’s Hospital Los Angeles is evaluating several novel devices for congenital heart disease—and recently performed the world’s first implant of a novel stent for babies.

Diagnosed with a rare lung disorder, Alessio faced an uncertain future. Today, he is thriving thanks to CHLA’s unique expertise.

Early treatment can help overcome this life-threatening condition in premature infants.

Normal lung (image A) compared to lung developed with low levels of VEGF (image B) demonstrating abnormal air spaces and lung tissue. Photo courtesy of Grikscheit Lab, The Saban Research Institute of